Analyst picks & changes

Interneuron Pharmaceuticals Inc.

(IPIC)

Patricia Lea of Argo Analysis said that the promise of bucindolol, a non-selective beta blocker owned by IPIC's

Read the full 223 word article

How to gain access

Continue reading with a
two-week free trial.